Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 45

1.

Repeated clinical malaria episodes are associated with modification of the immune system in children.

Bediako Y, Adams R, Reid AJ, Valletta JJ, Ndungu FM, Sodenkamp J, Mwacharo J, Ngoi JM, Kimani D, Kai O, Wambua J, Nyangweso G, de Villiers EP, Sanders M, Lotkowska ME, Lin JW, Manni S, Addy JWG, Recker M, Newbold C, Berriman M, Bejon P, Marsh K, Langhorne J.

BMC Med. 2019 Mar 13;17(1):60. doi: 10.1186/s12916-019-1292-y.

2.

Multiscale Immune Selection and the Transmission-Diversity Feedback in Antigenically Diverse Pathogen Systems.

Holding T, Valletta JJ, Recker M.

Am Nat. 2018 Dec;192(6):E189-E201. doi: 10.1086/699535. Epub 2018 Sep 5.

3.

Quantitative host resistance drives the evolution of increased virulence in an emerging pathogen.

Gates DE, Valletta JJ, Bonneaud C, Recker M.

J Evol Biol. 2018 Nov;31(11):1704-1714. doi: 10.1111/jeb.13366. Epub 2018 Sep 6.

PMID:
30107064
4.

Identification of immune signatures predictive of clinical protection from malaria.

Valletta JJ, Recker M.

PLoS Comput Biol. 2017 Oct 24;13(10):e1005812. doi: 10.1371/journal.pcbi.1005812. eCollection 2017 Oct.

5.

An Anti-β-Amyloid Vaccine for Treating Cognitive Deficits in a Mouse Model of Down Syndrome.

Belichenko PV, Madani R, Rey-Bellet L, Pihlgren M, Becker A, Plassard A, Vuillermot S, Giriens V, Nosheny RL, Kleschevnikov AM, Valletta JS, Bengtsson SK, Linke GR, Maloney MT, Hickman DT, Reis P, Granet A, Mlaki D, Lopez-Deber MP, Do L, Singhal N, Masliah E, Pearn ML, Pfeifer A, Muhs A, Mobley WC.

PLoS One. 2016 Mar 29;11(3):e0152471. doi: 10.1371/journal.pone.0152471. eCollection 2016.

6.

Daily energy expenditure, cardiorespiratory fitness and glycaemic control in people with type 1 diabetes.

Valletta JJ, Chipperfield AJ, Clough GF, Byrne CD.

PLoS One. 2014 May 14;9(5):e97534. doi: 10.1371/journal.pone.0097534. eCollection 2014.

7.

A Bayesian network for modelling blood glucose concentration and exercise in type 1 diabetes.

Ewings SM, Sahu SK, Valletta JJ, Byrne CD, Chipperfield AJ.

Stat Methods Med Res. 2015 Jun;24(3):342-72. doi: 10.1177/0962280214520732. Epub 2014 Feb 2.

PMID:
24492795
8.

Metabolic regulation during constant moderate physical exertion in extreme conditions in Type 1 diabetes.

Valletta JJ, Chipperfield AJ, Clough GF, Byrne CD.

Diabet Med. 2012 Jun;29(6):822-6. doi: 10.1111/j.1464-5491.2011.03453.x.

PMID:
21916974
9.

Restoration of norepinephrine-modulated contextual memory in a mouse model of Down syndrome.

Salehi A, Faizi M, Colas D, Valletta J, Laguna J, Takimoto-Kimura R, Kleschevnikov A, Wagner SL, Aisen P, Shamloo M, Mobley WC.

Sci Transl Med. 2009 Nov 18;1(7):7ra17. doi: 10.1126/scitranslmed.3000258.

10.

Gaussian Process modelling of blood glucose response to free-living physical activity data in people with type 1 diabetes.

Valletta JJ, Chipperfield AJ, Byrne CD.

Conf Proc IEEE Eng Med Biol Soc. 2009;2009:4913-6. doi: 10.1109/IEMBS.2009.5332466.

PMID:
19963637
11.

Sleep and EEG features in genetic models of Down syndrome.

Colas D, Valletta JS, Takimoto-Kimura R, Nishino S, Fujiki N, Mobley WC, Mignot E.

Neurobiol Dis. 2008 Apr;30(1):1-7. doi: 10.1016/j.nbd.2007.07.014. Epub 2007 Jul 21.

12.

A functional dynein-microtubule network is required for NGF signaling through the Rap1/MAPK pathway.

Wu C, Ramirez A, Cui B, Ding J, Delcroix JD, Valletta JS, Liu JJ, Yang Y, Chu S, Mobley WC.

Traffic. 2007 Nov;8(11):1503-20. Epub 2007 Sep 6.

13.

Increased App expression in a mouse model of Down's syndrome disrupts NGF transport and causes cholinergic neuron degeneration.

Salehi A, Delcroix JD, Belichenko PV, Zhan K, Wu C, Valletta JS, Takimoto-Kimura R, Kleschevnikov AM, Sambamurti K, Chung PP, Xia W, Villar A, Campbell WA, Kulnane LS, Nixon RA, Lamb BT, Epstein CJ, Stokin GB, Goldstein LS, Mobley WC.

Neuron. 2006 Jul 6;51(1):29-42.

14.

Trafficking the NGF signal: implications for normal and degenerating neurons.

Delcroix JD, Valletta J, Wu C, Howe CL, Lai CF, Cooper JD, Belichenko PV, Salehi A, Mobley WC.

Prog Brain Res. 2004;146:3-23.

PMID:
14699953
15.

NGF signaling in sensory neurons: evidence that early endosomes carry NGF retrograde signals.

Delcroix JD, Valletta JS, Wu C, Hunt SJ, Kowal AS, Mobley WC.

Neuron. 2003 Jul 3;39(1):69-84.

16.
17.

The extracellular domain of p75NTR is necessary to inhibit neurotrophin-3 signaling through TrkA.

Mischel PS, Smith SG, Vining ER, Valletta JS, Mobley WC, Reichardt LF.

J Biol Chem. 2001 Apr 6;276(14):11294-301. Epub 2001 Jan 9.

18.

Absence of p75NTR causes increased basal forebrain cholinergic neuron size, choline acetyltransferase activity, and target innervation.

Yeo TT, Chua-Couzens J, Butcher LL, Bredesen DE, Cooper JD, Valletta JS, Mobley WC, Longo FM.

J Neurosci. 1997 Oct 15;17(20):7594-605.

19.

Endocytosis of activated TrkA: evidence that nerve growth factor induces formation of signaling endosomes.

Grimes ML, Zhou J, Beattie EC, Yuen EC, Hall DE, Valletta JS, Topp KS, LaVail JH, Bunnett NW, Mobley WC.

J Neurosci. 1996 Dec 15;16(24):7950-64.

20.

A comprehensive study of the spatiotemporal pattern of beta-amyloid precursor protein mRNA and protein in the rat brain: lack of modulation by exogenously applied nerve growth factor.

Neve RL, Valletta JS, Li Y, Ventosa-Michelman M, Holtzman DM, Mobley WC.

Brain Res Mol Brain Res. 1996 Jul;39(1-2):185-97.

PMID:
8804727
21.

Multiple levels for regulation of TrkA in PC12 cells by nerve growth factor.

Zhou J, Valletta JS, Grimes ML, Mobley WC.

J Neurochem. 1995 Sep;65(3):1146-56.

PMID:
7543930
22.

p140trk mRNA marks NGF-responsive forebrain neurons: evidence that trk gene expression is induced by NGF.

Holtzman DM, Li Y, Parada LF, Kinsman S, Chen CK, Valletta JS, Zhou J, Long JB, Mobley WC.

Neuron. 1992 Sep;9(3):465-78.

PMID:
1524827
23.

Nerve growth factor induces gene expression of the prion protein and beta-amyloid protein precursor in the developing hamster central nervous system.

McKinley MP, Longo FM, Valletta JS, Rahbar F, Neve RL, Prusiner SB, Mobley WC.

Prog Brain Res. 1990;86:227-38. No abstract available.

PMID:
1982367
24.

Developmental regulation of nerve growth factor and its receptor in the rat caudate-putamen.

Mobley WC, Woo JE, Edwards RH, Riopelle RJ, Longo FM, Weskamp G, Otten U, Valletta JS, Johnston MV.

Neuron. 1989 Nov;3(5):655-64.

PMID:
2561975
25.

[A notice to rejuvenate].

Valletta J.

Cah Anesthesiol. 1969 Nov;17(7):835-47. French. No abstract available.

PMID:
4912490
26.

[Agitation in the postoperative period].

Valletta J.

Cah Anesthesiol. 1969 Mar;17(2):193-209 passim. French. No abstract available.

PMID:
5382516
27.

[Operation "disease" and postoperative resuscitation].

Valletta J.

Rev Infirm Assist Soc. 1969 Feb;19(2):117-27. French. No abstract available.

PMID:
4182558
28.

[Use of a new respiratory analeptic, piperidino-methyl-cyclohexane (camphosulfonate) (S.D. 210.37) in ventilatory insufficiency and as a recovery agent in anesthesiology].

Boissier JR, Valletta J, Bretagne M.

Cah Anesthesiol. 1968 Jan-Feb;16(1):75-83. French. No abstract available.

PMID:
4392465
29.

[Anesthesia for the surgery of strabismus].

Valletta J.

Arch Ophtalmol Rev Gen Ophtalmol. 1966 Sep;26(6):589-94. French. No abstract available.

PMID:
4226302
30.

[Clinical trials of a new anticholinesterase agent, galanthamine, in anesthesiology].

Bretagne M, Valletta J.

Anesth Analg (Paris). 1965 Apr-Jun;22(2):285-92. French. No abstract available.

PMID:
5832208
31.

[HEXAMETHONIUM, A NEW HYPOTENSIVE AND MYDRIATIC DRUG. ITS USE IN OPHTHALMOLOGICAL SURGERY].

OFFRET G, VALLETTA J, COSCAS G.

Arch Ophtalmol Rev Gen Ophtalmol. 1963 Jul-Aug;23:441-52. French. No abstract available.

PMID:
14071484
32.

[Ocular hypotension induced by hexamethonium].

OFFRET G, VALLETTA J, COSCAS G.

Ann Ocul (Paris). 1963 Jun;196:621-2. French. No abstract available.

PMID:
13939544
33.

[General anesthesia in ophthalmology].

LOMBARD G, VALLETTA J.

Ann Ocul (Paris). 1961 Apr;194:339-40. French. No abstract available.

PMID:
13763261
34.

[Prevention of the venous complications of pentothal: pH of the injected solutions].

VALLETTA J.

Anesth Analg (Paris). 1960 Sep-Dec;17:457-61. French. No abstract available.

PMID:
13779822
35.

[Argument in favor of general anesthesia in ophthalmology].

OFFRET G, VALLETTA J.

Bull Soc Ophtalmol Fr. 1959 Nov;8:615-9. French. No abstract available.

PMID:
14428367
36.

[Surgery of pain: the electric finger].

DIECKMANN G, VALLETTA J.

Concours Med. 1958 Oct 4;80(40):4183-4 passim. No abstract available.

PMID:
13585809
37.

[The limits of preventing anaesthetic adverse effects in the post-operative period].

VALLETTA J.

Anesth Analg (Paris). 1957 Jan-Feb;14(1):129-32; discussion 132-4. French. No abstract available.

PMID:
15445002
38.

[Is premedication always necessary].

VALLETTA J.

Anesth Anal. 1954 Feb;11(1):102-10; discussion, 110-7. Undetermined Language. No abstract available.

PMID:
15444554
39.

[Fear and anxiety in surgical patients].

VALLETTA J.

Prog Med (Paris). 1954 Jan 10;82(1):7-13. Undetermined Language. No abstract available.

PMID:
13145646
40.

L'anesthésie générale en ophtalmologie.

VALLETTA J.

Arch Ophtalmol Rev Gen Ophtalmol. 1954;14(3):274-9. No abstract available.

PMID:
13181567
41.

[Cancer of the cervical esophagus; total esophagectomy and pharyngo-gastrostomy in one stage].

PERROTIN J, VALLETTA J.

Mem Acad Chir (Paris). 1952 Dec 10-17;78(33-34):928-31. Undetermined Language. No abstract available.

PMID:
13046107
42.

[60 Cases of cancer of the esophagus and the upper part of the stomach; 30 resections and total gastrectomies].

PERROTIN J, VALLETTA J.

Presse Med. 1952 May 7;60(31):666-9. Undetermined Language. No abstract available.

PMID:
14948947
43.

[General glance on anesthesia].

VALLETTA J.

J Prat Rev Gen Clin Ther. 1950 Dec 21;64(51):622. Undetermined Language. No abstract available.

PMID:
14825260
44.

Le côté psychologique de l'allaitement.

VALLETTA J.

J Prat Rev Gen Clin Ther. 1948 Apr 8;62(15):181. Undetermined Language. No abstract available.

PMID:
18868114
45.

Ce que l'on peut demander à l'examen histologique du placenta.

VALLETTA J.

J Prat Rev Gen Clin Ther. 1948 Jan 29;62(5):53. Undetermined Language. No abstract available.

PMID:
18912955

Supplemental Content

Loading ...
Support Center